Argan (AGX) vs Legence (LGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Argan (AGX) has outperformed Legence (LGN) over the past year, losing 19.8% versus a loss of 20.8%. Legence is the larger company by market cap ($5.01 billion vs $3.77 billion), about 1.3 times the size. On valuation, Legence trades at a lower forward P/E (11.2x vs 16.7x for Argan).
Argan pays a dividend yielding 0.74%, while Legence does not currently pay one. Argan converts more of its revenue into profit, with a net margin of 14.6% versus -2.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGX | LGN |
|---|---|---|
| Share price | $268.94 | $32.31 |
| Market cap | $3.77B | $5.01B |
| 1-day change | -9.10% | -7.92% |
| YTD return | -14.16% | -24.93% |
| 1-year return | -19.80% | -20.75% |
| 5-year return | +564.87% | — |
| P/E ratio (TTM) | 21.26 | 82.85 |
| Forward P/E | 16.70 | 11.24 |
| EPS (TTM) | $12.65 | $0.39 |
| Dividend yield | 0.74% | 0.00% |
| Annual dividend | $2.00 | $0.00 |
| Revenue (latest FY) | $944.61M | $2.55B |
| Revenue growth (YoY) | +8.06% | +21.53% |
| Net income (latest FY) | $137.77M | $-59.78M |
| Gross margin | 20.50% | 21.01% |
| Operating margin | 14.26% | 2.41% |
| Net margin | 14.59% | -2.34% |
| 52-week high | $805.75 | $107.24 |
| 52-week low | $252.88 | $23.90 |
| Distance from 52-week high | -66.62% | -69.87% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +112.13% | +115.20% |
| Average volume | 356.08K | 1.39M |
| Shares outstanding | 14.03M | 77.29M |
| Employees | 1,409 | 7,000 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Engineering & Construction | Engineering & Construction |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Legence trades at a higher earnings multiple (82.8x vs 21.3x trailing P/E).
- Argan is more profitable, keeping 14.6 cents of every revenue dollar as net income versus -2.3 cents for Legence.
- Legence grew revenue faster in its latest fiscal year (+21.53% vs +8.06%).
About Argan
AGX stock →Argan, Inc., through its subsidiaries, provides engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services to the power generation market in the United States, Republic of Ireland, and the United Kingdom. It operates through three segments: Power, Industrial, and Teledata.
Consumer Discretionary · Engineering & Construction · 1,409 employees
About Legence
LGN stock →Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings in the United States.
Consumer Discretionary · Engineering & Construction · 7,000 employees
AGX vs LGN FAQ
Which is bigger, Argan or Legence?
Legence (LGN) is larger, with a market capitalization of $5.01B compared with $3.77B for Argan (AGX).
Which stock has performed better over the past year, AGX or LGN?
AGX returned -19.80% over the past 12 months, compared with -20.75% for LGN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, AGX or LGN?
AGX has the lower trailing P/E at 21.3, versus 82.8 for LGN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Argan or Legence?
Argan pays a dividend yielding 0.74%, while Legence does not currently pay a regular dividend.
Are Argan and Legence in the same industry?
Yes. Both are classified in the Engineering & Construction industry within the Consumer Discretionary sector.